COVID-19-Associated Liver Injury.

Daniel T Gildea Stephanie M WooCorinne E O'ConnorAmol S Rangnekar

Published in: Hepatic medicine : evidence and research (2023)

This review analyzes data regarding liver injury associated with COVID-19 infection. We discuss reported effects on the liver from both COVID-19 and COVID-19 treatment as well as pathophysiology, review the potential role of drug-induced liver injury as an etiology of COVID-19-associated liver injury, and touch on other reports of significant outcomes including COVID-19 cholangiopathy and autoimmune hepatitis. Finally, we review the implications of COVID-19 infection in liver transplant recipients.

Keyphrases

liver injury
drug induced
coronavirus disease
sars cov
adverse drug
respiratory syndrome coronavirus
type diabetes
multiple sclerosis
adipose tissue
metabolic syndrome
skeletal muscle
human health
glycemic control
insulin resistance